News item
Updates to Authorised Prescriber (AP) scheme requirements when accessing MDMA and psilocybine
We have published the outcomes from the targeted consultation, roundtable and stakeholder discussions reviewing certain Authorised Prescriber (AP) scheme requirements for accessing MDMA and psilocybine.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.